KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Globus Medical (GMED) EBITDA (2016 - 2025)

Historic EBITDA for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $119.7 million.

  • Globus Medical's EBITDA rose 11094.07% to $119.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $441.7 million, marking a year-over-year increase of 32761.75%. This contributed to the annual value of $106.3 million for FY2024, which is 2257.36% down from last year.
  • According to the latest figures from Q3 2025, Globus Medical's EBITDA is $119.7 million, which was up 11094.07% from $215.3 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's EBITDA registered a high of $215.3 million during Q2 2025, and its lowest value of -$8.0 million during Q1 2024.
  • In the last 5 years, Globus Medical's EBITDA had a median value of $41.8 million in 2021 and averaged $51.0 million.
  • Data for Globus Medical's EBITDA shows a peak YoY increase of 416817.16% (in 2024) and a maximum YoY decrease of 11466.77% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows Globus Medical's EBITDA stood at $11.4 million in 2021, then surged by 406.38% to $57.7 million in 2022, then tumbled by 59.11% to $23.6 million in 2023, then rose by 12.85% to $26.6 million in 2024, then skyrocketed by 349.71% to $119.7 million in 2025.
  • Its last three reported values are $119.7 million in Q3 2025, $215.3 million for Q2 2025, and $80.2 million during Q1 2025.